Company news

Aroa Biosurgery Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers

October 5, 2026

Symphony Significantly Improves DFU Healing

October 4, 2026

Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction

September 6, 2026

FY26 Full Year Results Presentation

May 25, 2026

FY26 Appendix 4E and Full Year Results

May 25, 2026

ARX FY26 Preliminary Results

April 29, 2026

Symphony Randomised Control Trial Complete

March 29, 2026

AROA Business Update Presentation

February 2, 2026

AROA Business Update

February 2, 2026

Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.

January 20, 2026

Aroa Biosurgery H1 FY26 Results

November 24, 2025

Appendix 4D and Half Year Report

November 24, 2025

September 2025 Quarterly Report and Appendix 4C

October 15, 2025

First clinical evidence published on AROA's ENIVO™ system for surgical dead space management.

August 26, 2025

June 2025 Quarterly Report and Appendix 4C

July 28, 2025

FY25 Full Year Results Presentation

May 28, 2025

FY25 Appendix 4E and Full Year Results

May 28, 2025

AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.

May 1, 2025

March 2025 Quarterly Report and Appendix 4C

April 28, 2025

December 2024 Quarterly Report and Appendix 4C

January 28, 2025

Aroa Half Year Results Presentation

November 25, 2024

Aroa Biosurgery Half Yearly Results H1 FY25

November 25, 2024

September 2024 Quarterly Report and Appendix 4C

October 21, 2024

June 2024 Quarterly Report and Appendix 4C

July 23, 2024

FY24 Full Year Results Presentation

May 20, 2024

FY24 Appendix 4E and Full Year Results

May 20, 2024

March 2024 Quarterly Report and Appendix 4C

April 29, 2024

December 2023 Quarterly Report and Appendix 4C

January 29, 2024

Aroa Biosurgery Half Yearly Results H1 FY24

November 27, 2023

September 2023 Quarterly Report and Appendix 4C

October 30, 2023

June 2023 Quarterly Report and Appendix 4C

July 30, 2023

FY23 Full Year Results Presentation

May 30, 2023

FY23 Appendix 4E and Full Year Results

May 30, 2023

March 2023 Quarterly Report and Appendix 4C

April 26, 2023

AROA secures first FDA clearance for ENIVO system

April 11, 2023

December 2022 Quarterly Report and Appendix 4C

January 30, 2023

Aroa Biosurgery Half Yearly Report H1 FY23

November 30, 2022

Aroa Biosurgery Announces Half Year Results

November 29, 2022

Aroa Biosurgery Half Yearly Results H1 FY23

November 28, 2022

September 2022 Quarterly Report and Appendix 4C

October 24, 2022

June Quarterly Report and Appendix 4C

July 25, 2022

FY22 Full Year Results Presentation

May 23, 2022

FY22 Appendix 4E and Full Year Results

May 23, 2022

March Quarterly Report and Appendix 4C

April 25, 2022

December Quarterly Report and Appendix 4C

January 27, 2022

Aroa Biosurgery Half Yearly Report H1 FY21

November 24, 2021

September Quarterly Report and Appendix 4C

October 26, 2021

Aroa delivers strong half, Myriad GPO win

October 5, 2021

Investor Presentation

July 28, 2021

Aroa Completes $47m Placement and Launches $5m SPP

July 28, 2021

Older news releases →

Decks

The 5 newest of 39 decks. Every deck is listed under its year.